CDK9-IN-24 (compound 21a) is a highly selective CDK9 inhibitor with significant inhibitory effect on tumor growth. CDK9-IN-24 effectively blocks cell proliferation and induces apoptosis by downregulating Mcl-1 and c-Myc, and can be used in acute myeloid
Molecular Weight:
461.55
Formula:
C27H31N3O4
Target:
Apoptosis,CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted